These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21746963)

  • 1. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
    Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
    J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses.
    Marusic S; Thakker P; Pelker JW; Stedman NL; Lee KL; McKew JC; Han L; Xu X; Wolf SF; Borey AJ; Cui J; Shen MW; Donahue F; Hassan-Zahraee M; Leach MW; Shimizu T; Clark JD
    J Neuroimmunol; 2008 Nov; 204(1-2):29-37. PubMed ID: 18829119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
    Hofstetter HH; Toyka KV; Gold R
    Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ; Cohen IR; Nussbaum G
    J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
    Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
    J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS.
    Lélu K; Delpy L; Robert V; Foulon E; Laffont S; Pelletier L; Engelhardt B; Guéry JC
    Eur J Immunol; 2010 Dec; 40(12):3489-98. PubMed ID: 21108469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
    Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
    Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
    Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
    J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
    Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
    J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
    Marusic S; Leach MW; Pelker JW; Azoitei ML; Uozumi N; Cui J; Shen MW; DeClercq CM; Miyashiro JS; Carito BA; Thakker P; Simmons DL; Leonard JP; Shimizu T; Clark JD
    J Exp Med; 2005 Sep; 202(6):841-51. PubMed ID: 16172261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M; Sawitzky M; Fontana A; Suter T
    Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T
    J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells.
    Han D; Tian Y; Zhang M; Zhou Z; Lu J
    Gene Ther; 2007 Mar; 14(5):383-95. PubMed ID: 17066098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
    Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.